Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CHOLESTECH CORPORATION ANNOUNCES FDA CLEARANCE OF NEW TEST PANEL.


HAYWARD, CA--(BUSINESS WIRE)--April 18, 1995--Cholestech Corporation (Nasdaq: CTEC CTEC Course and Teacher Evaluation Council (Northwestern University, Office of the Register)
CTEC Certified Technical Education Center
CTEC Certified Technical Education Center (Microsoft) 
) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) to market a new diagnostic test panel for the Cholestech L%D%X( System. The TC/Glucose panel simultaneously measures total cholesterol and glucose and, as with all of CholestechUs tests, requires only a single drop of whole blood to provide results in less than five minutes.

Mr. Warren E. Pinckert II, Cholestech's President and Chief Executive Officer, stated, "Testing for HDL (Hardware Description Language) A language used to describe the functions of an electronic circuit for documentation, simulation or logic synthesis (or all three). Although many proprietary HDLs have been developed, Verilog and VHDL are the major standards.  is now recommended, in addition to testing for total cholesterol to determine the risk of heart disease, by the National Cholesterol Education Program The National Cholesterol Education Program is a program managed by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. Its goal is to reduce increased cardiovascular disease rates due to hypercholesterolemia (elevated cholesterol . However, for those customers involved in health promotion that have not yet made the transition to this higher level of care, TC/Glucose can provide an economical and efficient method to offer screening for both coronary heart disease coronary heart disease: see coronary artery disease.
coronary heart disease
 or ischemic heart disease

Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis).
 and diabetes. Until now healthcare providers typically ran two different instruments or two separate tests to get total cholesterol and glucose results. With the strong relationship that has been shown between heart disease and diabetes, this new panel provides the benefit of added convenience on a system with proven accuracy."

Commenting further Mr. Pinckert said, "The Cholestech L%D%X is the only instrument on the market in the United States that can provide total cholesterol and glucose results simultaneously from one drop of blood in less than five minutes.S The TC/Glucose panel is the latest addition to CholestechUs full line of lipid and glucose test glucose test See 1 Glucose, see there 2 Glucose tolerance test, see there  cassettes, which include: TC, TCJand HDL, TC%HDL%GLU (language) GLU - A practical coarse grain implementation of the Lucid dataflow language for networks. , Lipid Profile, Lipid Profile plus Glucose.

Cholestech Corporation is committed to helping people lead longer, healthier and more active lives by promoting accurate preventive health care screening and monitoring of diseases in a point-of-care setting.

CONTACT: Cholestech Corporation

Lola Moenich, 510/293-8096
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 18, 1995
Words:308
Previous Article:Unison Software's RoadRunner backup product offers powerful new networking features.
Next Article:COGNOS RELEASES POWERPLAY 4.1 MULTIDIMENSIONAL DATA ANALYSIS FOR THE DESKTOP.
Topics:



Related Articles
Cholestech announces first quarter results.
Cholestech L.D.X System Chosen for APhA Foundation Project Impact Study; Cholestech Also Announces that Blue Cross Blue Shield of South Carolina will...
Cholestech L.D.X. System receives waiver from key federal regulation; quick, accurate blood analyzer now more accessible for physicians, pharmacists,...
Cholestech Corporation Announces Fiscal 1996 Results.
Cholestech Corporation Announces Agreement With Metra Biosystems on Bone Resorption.
Cholestech Corporation Announces the Signing of a Distribution Agreement with General Medical Corporation.
Cholestech announces second quarter fiscal 1997 results and reviews quarter's activity.
Cholestech Corporation Announces Promotion of Robert J. Dominici to Chief Operating Officer -- Diagnostic Products.
Cholestech Corporation Announces Promotion of Timothy I. Still to Vice President, Sales & Marketing -- Diagnostic Products.
MORE IN-OFFICE TESTING OK'D FOR CHOLESTEROL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles